BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 30048707)

  • 1. 20-HETE in the regulation of vascular and cardiac function.
    Rocic P; Schwartzman ML
    Pharmacol Ther; 2018 Dec; 192():74-87. PubMed ID: 30048707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (G
    Garcia V; Gilani A; Shkolnik B; Pandey V; Zhang FF; Dakarapu R; Gandham SK; Reddy NR; Graves JP; Gruzdev A; Zeldin DC; Capdevila JH; Falck JR; Schwartzman ML
    Circ Res; 2017 May; 120(11):1776-1788. PubMed ID: 28325781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of 20-HETE in cardiovascular diseases and its risk factors.
    Waldman M; Peterson SJ; Arad M; Hochhauser E
    Prostaglandins Other Lipid Mediat; 2016 Sep; 125():108-17. PubMed ID: 27287720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conflicting roles of 20-HETE in hypertension and renal end organ damage.
    Zhang C; Booz GW; Yu Q; He X; Wang S; Fan F
    Eur J Pharmacol; 2018 Aug; 833():190-200. PubMed ID: 29886242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 20-HETE in neovascularization.
    Chen L; Ackerman R; Guo AM
    Prostaglandins Other Lipid Mediat; 2012 Aug; 98(3-4):63-8. PubMed ID: 22227460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CYP/20-HETE/GPR75 axis in hypertension.
    Froogh G; Garcia V; Laniado Schwartzman M
    Adv Pharmacol; 2022; 94():1-25. PubMed ID: 35659370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.
    Imig JD
    Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocytic cytochrome P450 4A/20-hydroxyeicosatetraenoic acid contributes to angiogenesis in the experimental ischemic stroke.
    Liu Y; Li Y; Zhan M; Liu Y; Li Z; Li J; Cheng G; Teng G; Lu L
    Brain Res; 2019 Apr; 1708():160-170. PubMed ID: 30571981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 20-hydroxyeicosatetraenoic acid, endothelial dysfunction and hypertension.
    Pat Kunert M; Drenjancević I
    Med Glas (Zenica); 2011 Aug; 8(2):170-80. PubMed ID: 21849935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in pulmonary vascular remodeling and vascular angiogenesis associated with hypoxic pulmonary hypertension.
    Ma C; Li Y; Ma J; Liu Y; Li Q; Niu S; Shen Z; Zhang L; Pan Z; Zhu D
    Hypertension; 2011 Oct; 58(4):679-88. PubMed ID: 21859965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 20-Hydroxyeicosatetraenoic acid is a potential therapeutic target in cardiovascular diseases.
    Elshenawy OH; Anwar-Mohamed A; El-Kadi AO
    Curr Drug Metab; 2013 Jul; 14(6):706-19. PubMed ID: 23701160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments on the vascular effects of 20-hydroxyeicosatetraenoic acid.
    Garcia V; Schwartzman ML
    Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):74-82. PubMed ID: 27906746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.
    Fan F; Ge Y; Lv W; Elliott MR; Muroya Y; Hirata T; Booz GW; Roman RJ
    Front Biosci (Landmark Ed); 2016 Jun; 21(7):1427-63. PubMed ID: 27100515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation.
    Kroetz DL; Xu F
    Annu Rev Pharmacol Toxicol; 2005; 45():413-38. PubMed ID: 15822183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular actions of 20-HETE.
    Hoopes SL; Garcia V; Edin ML; Schwartzman ML; Zeldin DC
    Prostaglandins Other Lipid Mediat; 2015 Jul; 120():9-16. PubMed ID: 25813407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress of studies in 20-hydroxyeicosatetraenoic acid on vascular endothelium].
    Li H; Zhu Y
    Sheng Li Ke Xue Jin Zhan; 2013 Feb; 44(1):1-5. PubMed ID: 23671992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular characterization of mice with endothelial expression of cytochrome P450 4F2.
    Cheng J; Edin ML; Hoopes SL; Li H; Bradbury JA; Graves JP; DeGraff LM; Lih FB; Garcia V; Shaik JS; Tomer KB; Flake GP; Falck JR; Lee CR; Poloyac SM; Schwartzman ML; Zeldin DC
    FASEB J; 2014 Jul; 28(7):2915-31. PubMed ID: 24668751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CYP 4A ω-hydroxylase and formation of 20-hydroxyeicosatetreanoic acid (20-HETE) in cultured rat brain astrocytes.
    Gebremedhin D; Zhang DX; Carver KA; Rau N; Rarick KR; Roman RJ; Harder DR
    Prostaglandins Other Lipid Mediat; 2016 Jul; 124():16-26. PubMed ID: 27174801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.
    Miyata N; Roman RJ
    J Smooth Muscle Res; 2005 Aug; 41(4):175-93. PubMed ID: 16258232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 20-HETE contributes to myogenic activation of skeletal muscle resistance arteries in Brown Norway and Sprague-Dawley rats.
    Frisbee JC; Roman RJ; Falck JR; Krishna UM; Lombard JH
    Microcirculation; 2001 Feb; 8(1):45-55. PubMed ID: 11296852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.